Attivare Therapeutics receives $6.6M grant from Gates Foundation for advancing a new malaria vaccine.
Amount Raised
$6.6 Million
Round Type
Grant
NatickBiotechnologyHealth CareTherapeuticsInvestors
Description
Attivare Therapeutics, based in Natick, MA, has received $6.6M in grant funding from the Gates Foundation. The company will use the funds to advance its proprietary platform for developing a long-lasting malaria vaccine. Led by David Sherris, the technology focuses on utilizing biomaterial scaffolds for enhancing immune response. Their approach aims to improve vaccine durability while maximizing access for underserved populations.
Quick answer
Attivare Therapeutics raised $6.6 Million in a Grant round, dated December 15, 2025. Investors: Gates Foundation. Attivare Therapeutics is based in Natick, Massachusetts, United States.
- How much did Attivare Therapeutics raise?
- Attivare Therapeutics raised $6.6 Million in a Grant round on December 15, 2025.
- Who invested in Attivare Therapeutics?
- Gates Foundation is named as investors in this round.
- What does Attivare Therapeutics do?
- Attivare Therapeutics, Inc. is a pre-clinical stage biotechnology company pioneering new treatments for cancer and infectious diseases through its innovative immune-activating scaffold platform, ATTimmune.
- Where is Attivare Therapeutics based and how big is it?
- Attivare Therapeutics is based in Natick, Massachusetts, United States. Fundz records about 7 employees.
- Who are the decision-makers at Attivare Therapeutics?
- Fundz holds 1 contact at Attivare Therapeutics, including the Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Attivare Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
- PranaX raised $17M (Series A) on January 29, 2026.
- Altido Bio raised $13M (Seed) on January 28, 2026.
- Stellular Bio raised an undisclosed amount (Funding Round) on January 28, 2026.
- CraniUS raised $20M (Series B) on January 28, 2026.
- TRex Bio raised $50M (Funding Round) on January 27, 2026.
Who to call at Attivare Therapeutics, and when
A new round usually means Attivare Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Attivare Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Attivare Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Attivare Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Attivare Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Attivare Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.